Severe Refractory Euglycemic Ketoacidosis after Combined GLP 1 RA and SGLT 2i Therapy

A 36-year-old male with newly diagnosed type 2 diabetes developed severe euglycemic ketoacidosis after combined GLP-1 receptor agonist and SGLT-2 inhibitor therapy. Click here to learn more about the treatment approach.